Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest European Association of Urology Stories

2013-02-11 15:48:20

The safety of the patient is the prime consideration During the final day of the 28th Annual EAU Congress, which will take place on 15-19 March 2013 in Milan, the European Association of Urology will release its official policy statement on live surgery ethics. The statement and accompanying commentary will be delivered by Mr. Keith Parsons (Liverpool, UK), who chairs the EAU Guidelines Office and is a member of the working panel which was tasked with formulating the policy. Chaired by...

2013-01-28 08:25:36

AMSTERDAM, The Netherlands, January 28, 2013 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services, welcomes Dr. James Catto, MB ChB, PhD, FRCS (Urol), of the Academic Urology Unit, Royal Hallamshire Hospital in Sheffield (UK) as the new Editor-in-Chief of European Urology, the official journal of the European Association of Urology (EAU). The journal has been a prestigious...

2012-12-20 12:27:31

Health Policy Vice Chair Christopher Gonzalez joins others in expressing concerns about urology workforce shortages WASHINGTON, Dec. 20, 2012 /PRNewswire-USNewswire/ -- Primary care is not the only specialty being affected by physician shortages, and it is imperative that leaders and policy-makers also examine specialties such as urology when making decisions about graduate medical education, according to American Urological Association (AUA) representative Dr. Christopher Gonzalez, vice...

2012-02-29 15:01:00

Leading Clinicians Highlight Value of PCA3 Testing at Europe's Largest Urology Event QUEBEC CITY, Feb. 29, 2012 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a Quebec life sciences company that develops and commercializes high value cancer diagnostic tests, announced that PROGENSA((R) )PCA3 prostate cancer diagnostic test has been featured in seven presentations by leading professors and researchers at the 27(th) annual European Association of Urology (EAU) congress in Paris....

2011-07-21 12:19:00

RESTON, Va., July 21, 2011 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative, online, print, and live interactive continuing medical education and portal technologies for healthcare professionals, is pleased to announce the launch of its newest healthcare professional specialty portal, CCO Urology. CCO Urology content will include topics of interest to urologists, including prostate cancer, renal cell carcinoma, bladder cancer, and advances in...

2011-03-22 09:36:00

TOKYO, March 22, 2011 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.(TSE:4503,"Astellas") ( http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition[1,2]. These data were presented for the first time this week at...

2010-09-15 16:51:06

Latest TNS NIPO study underlines need for wide-scale, reliable screening A recent TNS NIPO survey, on behalf of the Dutch Association of Urology (NVU) and the European Association of Urology (EAU), showed that almost four out of 10 Dutch men of 50 years and older suffer, or have suffered, from urinary complaints. The same number of men also said in the same survey they are worried that they may have prostate cancer. The TNS NIPO survey also indicated that a significantly larger number of men...

2010-08-12 14:26:09

In European Urology, the official journal of the European Association of Urology, a new section will be published as of the September issue: Case Series of the month. This series is dedicated to publishing promising studies which have so far only preliminary results. The Case Series reports on no more than 10 patients and includes illustrative images. A Continuing Medical Education question with multiple choice answers is also included to enable readers to earn CME points. The first case...

2010-05-18 14:37:23

In the July issue of European Urology, the scientific journal of the European Association of Urology (EAU), S. Eggener et al. discussed in a recent study the significance and impact of focal therapy for low-risk cancer patients. Since the introduction of prostate cancer screening based on prostate-specific antigen (PSA), over-treatment has increased. A significant proportion of patients diagnosed with prostate cancer have well differentiated, low-volume tumors at minimal risk of impacting...

2010-04-19 09:15:27

Dr. Neal Shore (GB) presented for the first time in Europe the updated results of the study "Sipuleucel-T Active Cellular Immunotherapy for Metastatic, Castration-Resistant Prostate Cancer: results from the IMPACT trial," during the second plenary session of the 25th Anniversary EAU Congress in Barcelona. "This study shows a potential new treatment paradigm in oncology and is the first active immunotherapy to demonstrate improvement in overall survival (OS) for metastatic CRPC...